TP-3654
- Generic Name
- TP-3654
- Brand Names
- Relyvrio
- Drug Type
- Small Molecule
- Chemical Formula
- C22H25F3N4O
- CAS Number
- 1361951-15-6
- Unique Ingredient Identifier
- EOB0N7BOY4
- Background
Tauroursodeoxycholic acid, also known as ursodoxicoltaurine, is a highly hydrophilic tertiary bile acid that is produced in humans at a low concentration. It is a taurine conjugate of ursodeoxycholic acid with comparable therapeutic efficacy and safety, but a much higher hydrophilicity. Normally, hydrophilic bile acids regulates hydrophobic bile acids and ...
- Indication
Tauroursodeoxycholic acid is used to prevent and treat gallstone formation.
Tauroursodeoxycholic acid is used in combination with phenylbutyric acid to treat amyotrophic lateral sclerosis (ALS) in adults.
- Associated Conditions
- Amyotrophic Lateral Sclerosis (ALS), Gallstones
- Associated Therapies
- -
Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
Amylyx Pharmaceuticals reports positive Phase 2 HELIOS trial results for AMX0035 in Wolfram syndrome, showing sustained improvements in pancreatic function, glycemic control, and vision.
Related Clinical Trials:
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath